Use of Chinese medicine correlates negatively with the consumption of conventional medicine and medical cost in patients with uterine fibroids: a population-based retrospective cohort study in Taiwan

Table 4 Uterine fibroid-related cost in CM-users and nonusers

	Cost, US$/patient/year		Linear regression model^a
Type^b	CM nonusers	CM users	β (SE)	Pvalue
Total cost	6294 ± 41366	503.9 ± 4946	0.45 (1.05)	<0.0001
OPD	16.9 ± 146.5	4.57 ± 28.8	0.75 (1.02)	<0.0001
IPD	6274 ± 41317	480 ± 4833	0.26 (1.07)	<0.0001
surgery	2931 ± 19328	213 ± 1980	0.27 (1.07)	<0.0001
other (medication and admission)	3335 ± 25854	261.23 ± 3233	0.27 (1.07)	<0.0001
ER	2.111 ± 164.2	0.097 ± 3.51	0.60 (1.44)	<0.0001
CM	0.26 ± 7.37	18.7 ± 597.7	2.67 (1.17)	<0.0001

^aMultivariate linear regression model for nature log transformation of cost and model was adjusted for age, income, occupation, area, iron-deficiency anemia, infertility, excessive bleeding, and dysmenorrhea.
^bOPD, outpatients, IPD, inpatients, ER, emergency room, and CM, Chinese medicine.

ISSN: 2662-7671